Author:
Tarazona-Santabalbina Francisco José,Aguilella-Fernández Luis
Publisher
Springer Science and Business Media LLC
Subject
Geriatrics and Gerontology,Aging
Reference31 articles.
1. Kleerekoper M (2005) Prevention of postmenopausal bone loss and treatment of osteoporosis. Semin Reprod Med 23:141–148
2. Neviaser AS, Lane JM, Lenart BA, Edobor-Osula F, Lorich DG (2008) Low-energy femoral shaft fractures associated with alendronate use. J Orthop Trauma 22:346–350
3. Black D, Schwartz A, Ensrud K, Rybak-Feiglin A, Gupta J, Lombardi A, Wallace R, Levis S, Quandt S, Satterfield S, Cauley J, Cummings S (2004) A 5 year randomized trial of the long-term efficacy and safety of alendronate. J Bone Miner Res 10:S45
4. Bone HG, Schurr W (2004) Intravenous bisphosphonate therapy for osteoporosis: where do we stand? Curr Osteoporos Rep 2:24–30
5. Tonino RP, Meunier PJ, Emkey R, Rodriguez-Portales JA, Menkes CJ, Wasnich RD, Bone HG, Santora AC, Wu M, Desai R, Ross PD (2000) Skeletal benefits of alendronate: 7-year treatment of postmenopausal osteoporotic women. J Clin Endocrinol Metab 85:3109–3115
Cited by
18 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献